West Pharmaceutical Services (WST) Revenue & Quarterly History
Explore West Pharmaceutical Services, Inc. (WST) revenue from 2023 through the latest reported quarter, with SEC-sourced comparisons and filing-constrained analysis.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue for this quarter increased compared to the prior quarter. The year-over-year comparison also shows a significant rise from the same period one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$844.9M
Revenue reported for this quarter.
Quarter-over-quarter
+5.0%
Change from the immediately preceding quarter.
Year-over-year
+21.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $766.5M | +9.2% |
| Sep 30, 2025 | $804.6M | +7.7% |
| Dec 31, 2025 | $805M | +7.5% |
| Mar 31, 2026 | $844.9M | +21.0% |
Revenue performance
The reported revenue moved upward versus the immediately preceding quarter, continuing an upward trajectory. The sequential improvement aligns with the latest reported period.
Quarterly comparison
Compared to the same quarter one year ago, revenue was notably higher. This increase reflects a larger year-over-year gain than the quarter-over-quarter change.
What to watch
Monitor whether the upward revenue trend persists in the coming quarters.